Island Pharmaceuticals Ltd (ILA) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.237x

Based on the latest financial reports, Island Pharmaceuticals Ltd (ILA) has a cash flow conversion efficiency ratio of -0.237x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.69 Million ≈ $-1.20 Million USD) by net assets (AU$7.16 Million ≈ $5.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Island Pharmaceuticals Ltd's balance sheet to measure how much of total assets are equity-financed.

Island Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Island Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Island Pharmaceuticals Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Island Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Island Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Greenheart Gold Inc. V:GHRT	-0.089x
DYO Boya Fabrikalari Sanayi ve Ticaret AS IS:DYOBY	0.068x
Amata Summit Growth Freehold and Leasehold Real Estate Investment Trust BK:AMATAR	0.017x
Easy Field TWO:6425	0.074x
I-Tech ST:ITECH	0.048x
APCB Inc TW:6108	0.037x
Columbus Acquisition Corp Unit NASDAQ:COLAU	-0.002x
ATM Grupa S.A. WAR:ATG	0.012x

Annual Cash Flow Conversion Efficiency for Island Pharmaceuticals Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Island Pharmaceuticals Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Island Pharmaceuticals Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$7.16 Million ≈ $5.06 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.387x	+81.44%
2023-12-31	AU$1.52 Million ≈ $1.07 Million	AU$-3.16 Million ≈ $-2.24 Million	-2.084x	-37.34%
2022-12-31	AU$1.79 Million ≈ $1.26 Million	AU$-2.71 Million ≈ $-1.92 Million	-1.517x	-248.92%
2021-12-31	AU$4.32 Million ≈ $3.06 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.435x	-196.57%
2020-12-31	AU$6.40 Million ≈ $4.53 Million	AU$-938.24K ≈ $-663.86K	-0.147x	-702.06%
2019-12-31	AU$-657.00 ≈ $-464.87	AU$-16.00 ≈ $-11.32	0.024x	--

About Island Pharmaceuticals Ltd

AU:ILA Australia Biotechnology

Market Cap

$84.72 Million

AU$119.73 Million AUD

Market Cap Rank

#19800 Global

#644 in Australia

Share Price

AU$0.45

Change (1 day)

+7.23%

52-Week Range

AU$0.18 - AU$0.57

All Time High

AU$0.57